Medicine & Life Sciences
Trastuzumab
100%
Breast Neoplasms
66%
B 31
54%
Neoplasms
50%
Ovarian Neoplasms
45%
Drug Therapy
42%
African Americans
37%
Therapeutics
34%
edatrexate
29%
Multiple Myeloma
28%
Myelodysplastic Syndromes
27%
Survival
26%
Hispanic Americans
25%
Lapatinib
25%
Non-Hodgkin's Lymphoma
25%
European Continental Ancestry Group
25%
Estrogen Receptors
25%
Doxorubicin
24%
Pancreatic Neoplasms
24%
Appointments and Schedules
23%
Paclitaxel
23%
Acinar Cell Carcinoma
23%
Filgrastim
23%
Letrozole
22%
Cardiotoxicity
21%
Bone Marrow
21%
Platinum
21%
Clinical Trials
20%
gemcitabine
20%
Primary Myelofibrosis
20%
Lymphoma
20%
Vinblastine
19%
Pancreatic Carcinoma
19%
Incidence
19%
Biopsy
17%
MLN2238
17%
Plasma Cells
17%
Granulocyte Colony-Stimulating Factor
17%
Medicare
16%
Recurrence
15%
Thalidomide
14%
Ado-Trastuzumab Emtansine
14%
niraparib
14%
Carcinoma
14%
Quality of Life
14%
Non-Small Cell Lung Carcinoma
14%
ribociclib
14%
Cyclophosphamide
14%
durvalumab
13%
Apoptosis
13%